Τρίτη 9 Οκτωβρίου 2018

Real life treatment of Cholinergic Urticaria with Omalizumab

Retrospective analysis of omalizumab treatment in 16 cholinergic urticaria (CholU) patients revealed effectiveness in two third of the patients, especially in female patients. Most non-responders to standard-dosed omalizumab benefited from updosing. Non-responders raise the question of different pathomechanisms in these patients. (Source: Journal of Allergy and Clinical Immunology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.



from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2yaFLHE

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.